Akari Therapeutics (AKTX) Current Assets (2011 - 2026)
Akari Therapeutics recorded quarterly Current Assets of $3.6 million in Q1 2026, down 34.29% quarter-over-quarter from $5.5 million in Q4 2025, and up 7.17% year-over-year from $3.3 million in Q1 2025.
Akari Therapeutics' Current Assets history runs 16 years deep, the most recent figure standing at $3.6 million for Q1 2026.
- In Q1 2026, Current Assets rose 7.17% year-over-year to $3.6 million; the TTM figure through Mar 2026 stood at $3.6 million (up 7.17% YoY), while the FY2025 annual figure was $5.5 million, up 85.03% from the prior year.
- Current Assets came in at $3.6 million for Q1 2026 at Akari Therapeutics, down from $5.5 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $19.4 million in Q1 2022 to a low of $2.7 million in Q3 2024.
- A 5-year average of $6.4 million and a median of $4.0 million in 2023 frame the typical range for Current Assets.
- Across the five-year window, Current Assets jumped 148.72% in 2022 and sank 68.58% in 2023, its largest moves.
- Akari Therapeutics' Current Assets stood at $13.8 million in 2022, then tumbled by 68.58% to $4.3 million in 2023, then slumped by 32.0% to $3.0 million in 2024, then jumped by 85.03% to $5.5 million in 2025, then tumbled by 34.29% to $3.6 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $3.6 million, $5.5 million, and $2.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.21 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 1.97 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.59 Mn |
| Dec 31, 2025 | 5.46 Mn |
| Sep 30, 2025 | 2.95 Mn |
| Jun 30, 2025 | 3.30 Mn |
| Mar 31, 2025 | 3.35 Mn |
| Dec 31, 2024 | 2.95 Mn |
| Sep 30, 2024 | 2.73 Mn |
| Jun 30, 2024 | 5.08 Mn |
| Mar 31, 2024 | 2.77 Mn |
| Dec 31, 2023 | 4.34 Mn |
| Jun 30, 2023 | 8.00 Mn |
| Dec 31, 2022 | 13.82 Mn |
| Jun 30, 2022 | 11.35 Mn |
| Mar 31, 2022 | 19.43 Mn |
| Dec 31, 2021 | 11.63 Mn |
| Sep 30, 2021 | 14.69 Mn |
| Jun 30, 2021 | 4.80 Mn |
| Mar 31, 2021 | 7.81 Mn |
| Dec 31, 2020 | 21,415.00 |
| Sep 30, 2020 | 13.67 Mn |
| Jun 30, 2020 | 14.43 Mn |
| Mar 31, 2020 | 9.65 Mn |
| Dec 31, 2019 | 13,868.00 |
| Sep 30, 2019 | 10.23 Mn |
| Jun 30, 2019 | 4.55 Mn |
| Mar 31, 2019 | 8.03 Mn |
| Dec 31, 2018 | 7.45 Mn |
| Sep 30, 2018 | 12.04 Mn |
| Jun 30, 2018 | 16.52 Mn |
| Mar 31, 2018 | 25.27 Mn |
| Dec 31, 2017 | 28.81 Mn |
| Sep 30, 2017 | 22.19 Mn |
| Jun 30, 2017 | 31.81 Mn |
| Mar 31, 2017 | 36.28 Mn |
| Dec 31, 2016 | 45.63 Mn |
| Sep 30, 2016 | 51.82 Mn |
| Jun 30, 2016 | 57.37 Mn |
| Mar 31, 2016 | 62.69 Mn |
| Dec 31, 2015 | 69.66 Mn |
| Sep 30, 2015 | 78.94 Mn |
| Jun 30, 2015 | 2.92 Mn |
| Mar 31, 2015 | 4.27 Mn |
| Dec 31, 2014 | 3.34 Mn |
| Dec 31, 2013 | 7.83 Mn |
| Dec 31, 2012 | 1.12 Mn |
| Dec 31, 2011 | 27,000.00 |